About Laura Benjamin
Laura Benjamin is CEO, Board Director at Myris Therapeutics.
Experience
This experience comes from Laura Benjamin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Laura Benjamin in the role, so the role may have started earlier or lasted longer.
Myris Therapeutics, Inc. Current
CEO, Board Director
CEO and President, Myris Therapeutics (2023 – Present)
2023 – Present · Sharpsburg, PA
Develops antibody-linked medicines for people with cancer.
OT
OncXerna Therapeutics
CEO and President
2018 – 2023
AR
American Association for Cancer Research
Senior Editor for Cancer Research
2009 – 2018
EC
Eli Lilly and Company
Vice President, Oncology
2009 – 2016
HS
Harvard Medical School
Visiting Associate Professor of Pathology
1999 – 2012
TJ
The Hebrew University of Jerusalem
Postdoctoral Fellow
1995 – 1999
Key Colleagues at Startups
The people Laura Benjamin works with at each company, as listed on that company's latest Form D.
Myris Therapeutics, Inc. · Form D, Oct 14, 2026
RW
Rebecca Wolfe
Executive officer
AS
Antonina Simakova
Executive officer
Alan Russell
Promoter
David Colaizzi
Board Chairman
BF
Barbara Fox
Board Director
Krzysztof Matyjaszewski
Co-Founder and Board Director
Mark Murcko
Board Director